S&P 500   3,128.21 (-3.03%)
DOW   27,081.36 (-3.15%)
QQQ   215.37 (-2.72%)
AAPL   288.08 (-3.39%)
FB   196.77 (-1.97%)
MSFT   168.07 (-1.65%)
GOOGL   1,386.32 (-2.36%)
AMZN   1,972.74 (-1.82%)
CGC   19.62 (-3.35%)
NVDA   262.05 (-4.11%)
BABA   205.61 (-0.27%)
MU   52.10 (-5.29%)
GE   11.32 (-4.55%)
TSLA   799.91 (-4.06%)
AMD   47.57 (-3.16%)
T   37.35 (-1.84%)
ACB   1.51 (-2.58%)
F   7.23 (-4.49%)
NFLX   360.09 (-2.34%)
PRI   121.42 (-4.37%)
BAC   31.08 (-5.04%)
DIS   128.19 (-3.62%)
GILD   70.10 (-3.84%)
S&P 500   3,128.21 (-3.03%)
DOW   27,081.36 (-3.15%)
QQQ   215.37 (-2.72%)
AAPL   288.08 (-3.39%)
FB   196.77 (-1.97%)
MSFT   168.07 (-1.65%)
GOOGL   1,386.32 (-2.36%)
AMZN   1,972.74 (-1.82%)
CGC   19.62 (-3.35%)
NVDA   262.05 (-4.11%)
BABA   205.61 (-0.27%)
MU   52.10 (-5.29%)
GE   11.32 (-4.55%)
TSLA   799.91 (-4.06%)
AMD   47.57 (-3.16%)
T   37.35 (-1.84%)
ACB   1.51 (-2.58%)
F   7.23 (-4.49%)
NFLX   360.09 (-2.34%)
PRI   121.42 (-4.37%)
BAC   31.08 (-5.04%)
DIS   128.19 (-3.62%)
GILD   70.10 (-3.84%)
S&P 500   3,128.21 (-3.03%)
DOW   27,081.36 (-3.15%)
QQQ   215.37 (-2.72%)
AAPL   288.08 (-3.39%)
FB   196.77 (-1.97%)
MSFT   168.07 (-1.65%)
GOOGL   1,386.32 (-2.36%)
AMZN   1,972.74 (-1.82%)
CGC   19.62 (-3.35%)
NVDA   262.05 (-4.11%)
BABA   205.61 (-0.27%)
MU   52.10 (-5.29%)
GE   11.32 (-4.55%)
TSLA   799.91 (-4.06%)
AMD   47.57 (-3.16%)
T   37.35 (-1.84%)
ACB   1.51 (-2.58%)
F   7.23 (-4.49%)
NFLX   360.09 (-2.34%)
PRI   121.42 (-4.37%)
BAC   31.08 (-5.04%)
DIS   128.19 (-3.62%)
GILD   70.10 (-3.84%)
S&P 500   3,128.21 (-3.03%)
DOW   27,081.36 (-3.15%)
QQQ   215.37 (-2.72%)
AAPL   288.08 (-3.39%)
FB   196.77 (-1.97%)
MSFT   168.07 (-1.65%)
GOOGL   1,386.32 (-2.36%)
AMZN   1,972.74 (-1.82%)
CGC   19.62 (-3.35%)
NVDA   262.05 (-4.11%)
BABA   205.61 (-0.27%)
MU   52.10 (-5.29%)
GE   11.32 (-4.55%)
TSLA   799.91 (-4.06%)
AMD   47.57 (-3.16%)
T   37.35 (-1.84%)
ACB   1.51 (-2.58%)
F   7.23 (-4.49%)
NFLX   360.09 (-2.34%)
PRI   121.42 (-4.37%)
BAC   31.08 (-5.04%)
DIS   128.19 (-3.62%)
GILD   70.10 (-3.84%)
Log in

Alder Biopharmaceuticals SEC Filings & 10K Form (NASDAQ:ALDR)

$18.88
0.00 (0.00 %)
(As of 10/22/2019)
Today's Range
$18.88
Now: $18.88
$18.88
50-Day Range
$18.88
MA: $18.88
$18.88
52-Week Range
$8.39
Now: $18.88
$19.12
VolumeN/A
Average Volume5.12 million shs
Market Capitalization$1.58 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.64

SEC Filings

Alder Biopharmaceuticals (NASDAQ:ALDR) SEC Filings

DateFilerForm TypeView
02/13/2020
3:18 PM
Alder Biopharmaceuticals (Subject)
TPG Group Holdings Advisors, Inc. (0001495741) (Filed by)
Form SC 13G/A
11/01/2019
10:44 AM
Alder Biopharmaceuticals (Filer)
Form 15-12B
10/24/2019
6:30 PM
Alder Biopharmaceuticals (Issuer)
Campoy Carlos (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/24/2019
6:28 PM
Alder Biopharmaceuticals (Issuer)
STRECK PAUL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/24/2019
6:26 PM
Alder Biopharmaceuticals (Issuer)
Dac Nadia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/24/2019
6:17 PM
Alder Biopharmaceuticals (Issuer)
Green Jeremy (Reporting)
Redmile Group, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/24/2019
6:12 PM
Alder Biopharmaceuticals (Issuer)
Lavelle Erin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/24/2019
6:10 PM
Alder Biopharmaceuticals (Issuer)
Bucher James B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/24/2019
6:09 PM
Alder Biopharmaceuticals (Issuer)
Hassler Randal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/24/2019
6:07 PM
Alder Biopharmaceuticals (Issuer)
Smith Jeffrey T L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/24/2019
6:05 PM
Alder Biopharmaceuticals (Issuer)
YARNO WENDY L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/24/2019
6:03 PM
Alder Biopharmaceuticals (Issuer)
SIEGALL CLAY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/24/2019
6:01 PM
Alder Biopharmaceuticals (Issuer)
Preston Heather (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/24/2019
5:58 PM
Alder Biopharmaceuticals (Issuer)
Montgomery Alan Bruce (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/24/2019
5:56 PM
Alder Biopharmaceuticals (Issuer)
Cleveland Paul B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/24/2019
5:55 PM
Alder Biopharmaceuticals (Issuer)
Carter Paul Rutherford (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/24/2019
5:52 PM
Alder Biopharmaceuticals (Issuer)
Azelby Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/24/2019
5:43 PM
Alder Biopharmaceuticals (Issuer)
H LUNDBECK A S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/24/2019
3:28 PM
Alder Biopharmaceuticals (Subject)
Redmile Group, LLC (Filed by)
Form SC 13D/A
10/22/2019
4:32 PM
Alder Biopharmaceuticals (Filer)
Form POSASR
10/22/2019
4:13 PM
Alder Biopharmaceuticals (Filer)
Form S-8 POS
10/22/2019
4:11 PM
Alder Biopharmaceuticals (Filer)
Form S-8 POS
10/22/2019
4:09 PM
Alder Biopharmaceuticals (Filer)
Form S-8 POS
10/22/2019
4:08 PM
Alder Biopharmaceuticals (Filer)
Form S-8 POS
10/22/2019
4:06 PM
Alder Biopharmaceuticals (Filer)
Form S-8 POS
10/22/2019
4:04 PM
Alder Biopharmaceuticals (Filer)
Form S-8 POS
10/22/2019
4:03 PM
Alder Biopharmaceuticals (Filer)
Form S-8 POS
10/22/2019
8:26 AM
Alder Biopharmaceuticals (Subject)
The Nasdaq Stock Market LLC (Filed by)
Form 25-NSE
10/22/2019
8:15 AM
Alder Biopharmaceuticals (Subject)
Form SC 14D9/A
10/22/2019
8:03 AM
Alder Biopharmaceuticals (Subject)
H LUNDBECK A S (Filed by)
Form SC TO-T/A
10/22/2019
8:03 AM
Alder Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2019
4:02 PM
Alder Biopharmaceuticals (Subject)
H LUNDBECK A S (Filed by)
Form SC TO-T/A
10/16/2019
3:59 PM
Alder Biopharmaceuticals (Subject)
Form SC 14D9/A
10/11/2019
4:10 PM
Alder Biopharmaceuticals (Subject)
Form SC 14D9/A
10/10/2019
4:23 PM
Alder Biopharmaceuticals (Subject)
H LUNDBECK A S (Filed by)
Form SC TO-T/A
10/10/2019
11:47 AM
Alder Biopharmaceuticals (Subject)
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
Form SC 13G/A
10/10/2019
11:11 AM
Alder Biopharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
10/04/2019
4:29 PM
Alder Biopharmaceuticals (Subject)
H LUNDBECK A S (Filed by)
Form SC TO-T/A
10/04/2019
3:39 PM
Alder Biopharmaceuticals (Subject)
Form SC 14D9/A
10/01/2019
5:40 PM
Alder Biopharmaceuticals (Subject)
H LUNDBECK A S (Filed by)
Form SC TO-T/A
10/01/2019
3:50 PM
Alder Biopharmaceuticals (Subject)
Form SC 14D9/A
09/27/2019
3:33 PM
Alder Biopharmaceuticals (Subject)
H LUNDBECK A S (Filed by)
Form SC TO-T/A
09/26/2019
4:02 PM
Alder Biopharmaceuticals (Subject)
Form SC 14D9/A
09/26/2019
1:17 PM
Alder Biopharmaceuticals (Issuer)
H LUNDBECK A S (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/26/2019
12:26 PM
Alder Biopharmaceuticals (Subject)
H LUNDBECK A S (Filed by)
Form SC 13D
09/23/2019
3:08 PM
Alder Biopharmaceuticals (Subject)
Form SC 14D9
09/23/2019
2:24 PM
Alder Biopharmaceuticals (Subject)
H LUNDBECK A S (Filed by)
Form SC TO-T
09/18/2019
3:50 PM
Alder Biopharmaceuticals (Subject)
H LUNDBECK A S (Filed by)
Form SC TO-C
09/18/2019
3:45 PM
Alder Biopharmaceuticals (Issuer)
Smith Jeffrey T L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2019
3:20 PM
Alder Biopharmaceuticals (Subject)
Redmile Group, LLC (Filed by)
Form SC 13D/A
09/16/2019
4:14 PM
Alder Biopharmaceuticals (Subject)
Form SC14D9C
09/16/2019
4:05 PM
Alder Biopharmaceuticals (Subject)
H LUNDBECK A S (Filed by)
Form SC TO-C
09/16/2019
8:25 AM
Alder Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2019
3:15 PM
Alder Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2019
3:14 PM
Alder Biopharmaceuticals (Issuer)
Green Jeremy (Reporting)
Redmile Group, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2019
5:17 PM
Alder Biopharmaceuticals (Issuer)
YARNO WENDY L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2019
5:15 PM
Alder Biopharmaceuticals (Issuer)
SIEGALL CLAY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2019
5:14 PM
Alder Biopharmaceuticals (Issuer)
Montgomery Alan Bruce (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2019
5:12 PM
Alder Biopharmaceuticals (Issuer)
Carter Paul Rutherford (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2019
5:08 PM
Alder Biopharmaceuticals (Issuer)
Cleveland Paul B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2019
5:10 PM
Alder Biopharmaceuticals (Issuer)
Green Jeremy (Reporting)
Redmile Group, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2019
4:00 PM
Alder Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2019
4:12 PM
Alder Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2019
4:08 PM
Alder Biopharmaceuticals (Filer)
Form 424B7
05/02/2019
3:59 PM
Alder Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2019
3:50 PM
Alder Biopharmaceuticals (Filer)
Form DEF 14A
04/25/2019
5:56 PM
Alder Biopharmaceuticals (Issuer)
Azelby Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/25/2019
5:55 PM
Alder Biopharmaceuticals (Issuer)
Hassler Randal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/25/2019
5:53 PM
Alder Biopharmaceuticals (Issuer)
Benedict Larry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/25/2019
5:51 PM
Alder Biopharmaceuticals (Issuer)
Smith Jeffrey T L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/25/2019
5:49 PM
Alder Biopharmaceuticals (Issuer)
Lavelle Erin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/25/2019
5:43 PM
Alder Biopharmaceuticals (Issuer)
Bucher James B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2019
12:54 PM
Alder Biopharmaceuticals (Filer)
Form CT ORDER
04/12/2019
4:00 PM
Alder Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2019
4:40 PM
Alder Biopharmaceuticals (Issuer)
Dac Nadia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2019
4:36 PM
Alder Biopharmaceuticals (Issuer)
Dac Nadia (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/28/2019
4:16 PM
Alder Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2019
4:15 PM
Alder Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2019
9:00 AM
Alder Biopharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
03/06/2019
3:24 PM
Alder Biopharmaceuticals (Issuer)
Green Jeremy (Reporting)
Redmile Group, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2019
3:22 PM
Alder Biopharmaceuticals (Subject)
Redmile Group, LLC (Filed by)
Form SC 13D/A
03/05/2019
3:36 PM
Alder Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/01/2019
5:07 AM
Alder Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2019
5:10 AM
Alder Biopharmaceuticals (Filer)
Form 424B5
02/27/2019
5:39 AM
Alder Biopharmaceuticals (Filer)
Form 424B5
02/25/2019
3:52 PM
Alder Biopharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/25/2019
3:45 PM
Alder Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2019
12:50 PM
Alder Biopharmaceuticals (Subject)
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
Form SC 13G/A
02/13/2019
12:00 PM
Alder Biopharmaceuticals (Subject)
Foresite Capital Fund II, L.P. (Filed by)
Form SC 13G/A
02/11/2019
10:22 AM
Alder Biopharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/11/2019
10:06 AM
Alder Biopharmaceuticals (Subject)
BlackRock Inc. (Filed by)
Form SC 13G/A
02/08/2019
3:58 PM
Alder Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/08/2019
3:52 PM
Alder Biopharmaceuticals (Issuer)
Smith Jeffrey T L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
3:51 PM
Alder Biopharmaceuticals (Issuer)
Lavelle Erin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
3:47 PM
Alder Biopharmaceuticals (Issuer)
Latham John A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
3:45 PM
Alder Biopharmaceuticals (Issuer)
Hassler Randal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
3:43 PM
Alder Biopharmaceuticals (Issuer)
Bucher James B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
3:41 PM
Alder Biopharmaceuticals (Issuer)
Benedict Larry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2019
4:32 PM
Alder Biopharmaceuticals (Issuer)
STRECK PAUL (Reporting)
Form 4/A
01/23/2019
4:23 PM
Alder Biopharmaceuticals (Issuer)
STRECK PAUL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 2/25/2020 by MarketBeat.com Staff

Featured Article: Relative Strength Index

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel